When planning a technology transfer, choosing a CDMO partner with deep scientific, operational, and cross‑functional expertise can make all the difference. In this expert panel discussion on Thursday, February 26th, Rentschler Biopharma’s experts share real‑world lessons from supporting complex programs through phase‑appropriate development, scale‑up, and cGMP manufacturing. They offer a transparent look at what truly drives a smooth, efficient, and reliable tech‑transfer experience.

Join:

• Dante Lepore, Ph.D. — Laboratory Head, Downstream Process Development
• Jessica Feldman, Ph.D. — Senior Director, Process Development
• Patrick Cushing, Ph.D. — Vice President, Operations
• Robin Lynge — Senior Director, Business Development

Key Insights:

• Essential elements of a successful tech transfer

Core scientific and operational considerations as processes advance to cGMP production. 

• What to evaluate before initiating a transfer

How early alignment, molecule understanding, and process robustness reduce downstream complexity and risk.

• Pitfalls and blind spots

Practical insights into where transfers commonly encounter challenges—and how experienced teams plan ahead to mitigate them.

• Why strong execution creates lasting value

How clear planning, cross functional coordination, and predictable scale-up contribute to reliable timelines and overall project success.

Why attend?

Whether this is your first tech transfer or you’re optimizing a new phase of development, this panel offers grounded, experience driven guidance that can help you prepare effectively. Expect real examples and practical takeaways you can directly apply to your next transfer.